Boditech Med Inc. (KOSDAQ: 206640)

Market Cap	388.74B
Revenue (ttm)	139.13B
Net Income (ttm)	30.44B
Shares Out	21.98M
EPS (ttm)	1,386.14
PE Ratio	12.76
Forward PE	10.68
Dividend	200.00 (1.17%)
Ex-Dividend Date	Mar 29, 2024

Volume	74,962
Open	17,140
Previous Close	17,100
Day's Range	17,140 - 18,000
52-Week Range	13,400 - 22,150
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 12, 2024

About Boditech Med

Boditech Med Inc. offers instruments and diagnostic reagents in South Korea and internationally. The company offers instruments, including ichroma II, diagnostic immuno-analyzer to measure the presence of various biomarkers for cardiac, cancer, hormones, infectious diseases, autoimmune diseases, and metabolic diseases; ichroma III, a high-throughput immuno-analyzer that enables simultaneous testing for various parameters; ExAmplar, a compact real time PCR that detects virus/bacteria quantitatively or qualitatively using ready-to-use cartridges;...

• Industry: In Vitro and In Vivo Diagnostic Substances
• Founded: 1998
• Employees: 492
• Stock Exchange: KOSDAQ
• Ticker Symbol: 206640

Financial Performance

In 2023, Boditech Med's revenue was 134.22 billion, an increase of 13.67% compared to the previous year's 118.08 billion. Earnings were 25.95 billion, an increase of 7.43%.